Ami Organics Limited has informed the Exchange regarding a press release dated May 02, 2025, titled "Q4 & FY25 Results".
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ami Organics Limited reported strong financial results for Q4 and full year FY25, crossing the ₹1,000 crore revenue mark for the first time. FY25 revenue grew 40.3% year-on-year to ₹1,007 crore, with EBITDA up 80.6% to ₹232 crore and margins expanding by 514 basis points to 23.0%. Profit after tax nearly doubled, rising 98.6% to ₹160 crore. In Q4 alone, revenue rose 37.1% to ₹309 crore, while PAT jumped 144.2% to ₹63 crore with margins reaching 20.3%. The company also announced a rebranding from 'Ami Organics Limited' to 'Acutaas Chemicals Limited' to reflect its expansion into a diversified specialty chemicals business. Management guided for 25% revenue growth in FY26.
This is a strong earnings beat with double-digit growth in revenue, profits, and margins, likely to be viewed positively by the market. The rebranding signals the company's strategic pivot toward broader specialty chemicals beyond pharma intermediates, which could expand its addressable market. Forward guidance of 25% revenue growth suggests continued momentum, potentially supporting investor sentiment.